cytena® launches new x.sight™ series at BioProcess International European Summit 2018 in Amsterdam
Freiburg, Germany — The isolation, sorting and analysis of single biological cells has been rapidly gaining attention in the life-science sector over the last couple of years. cytena’s single-cell printing technology has rapidly gained adoption by the pharmaceutical industry for clonal cell line development as well as for single-cell analysis. Compared to alternative technologies, cytena’s unique advantages include fast and gentle handling of even the most sensitive cell types, and a single-use disposable printing cartridge to prevent cross-contamination.
